Sunesis Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference
Mar 06, 2018 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 06, 2018 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of...
Mar 06, 2018 12:00 pm UTC| Business
LEXINGTON, Mass., March 06, 2018 -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare,...
Antares Pharma to Report Fourth Quarter and Full Year 2017 Financial and Operating Results
Mar 06, 2018 12:00 pm UTC| Business
EWING, N.J., March 06, 2018 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2017 financial results and recent operating progress before the market opens on Tuesday,...
Tonix Pharmaceuticals to Present at the 30th Annual ROTH Conference
Mar 06, 2018 12:00 pm UTC| Business
NEW YORK, March 06, 2018 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat serious...
Merus to Present at the Cowen & Co. 38th Annual Health Care Conference
Mar 06, 2018 12:00 pm UTC| Business
UTRECHT, The Netherlands, March 06, 2018 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that Ton Logtenberg,...
Cesca Therapeutics Inc. to Present at BIO-Europe Spring® 2018
Mar 06, 2018 12:00 pm UTC| Business
RANCHO CORDOVA, Calif., March 06, 2018 -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) today announced that Joe Balagot, senior vice president of corporate development, will present an overview of the company, with a...
Mar 06, 2018 12:00 pm UTC| Business
HOUSTON, March 06, 2018 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the...